“Efficacy and Safety Results of Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: 16-Week Results From SPROUT, a Phase 3, Randomized, Controlled Study”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 2, Mar. 2023, p. s109, https://doi.org/10.25251/skin.7.supp.109.